BEAM vs FEAM high-dose chemotherapy: retrospective study in lymphoma patients undergoing autologous stem cell transplant

Bone Marrow Transplant. 2018 Aug;53(8):1051-1054. doi: 10.1038/s41409-018-0120-x. Epub 2018 Feb 13.

Authors

F Marchesi¹, S Capria², D Giannarelli³, S M Trisolini², M Ansuinelli², M D Caputo², A Serrao², S Gumenyuk⁴, D Renzi⁴, L Pupo⁵, F Palombi⁴, I Provenzano⁵, A Di Rocco², F Pisani⁴, A Romano⁴, A Spadea⁴, E Papa⁴, M Canfora⁶, M Cantonetti⁵, A Mengarelli⁴

Affiliations

¹ Hematology and Stem Cell Transplant Unit, Experimental and Clinical Oncology Department, IRCCS Regina Elena National Cancer Institute, Rome, Italy. francesco.marchesi@ifo.gov.it.
² Hematology Unit, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto I, La Sapienza University, Rome, Italy.
³ Biostatistical Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
⁴ Hematology and Stem Cell Transplant Unit, Experimental and Clinical Oncology Department, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
⁵ Hematology Unit, Tor Vergata University, Rome, Italy.
⁶ Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

PMID: 29440737
DOI: 10.1038/s41409-018-0120-x

No abstract available

MeSH terms

Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols / pharmacology
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carmustine / pharmacology
Carmustine / therapeutic use
Cytarabine / pharmacology
Cytarabine / therapeutic use
Etoposide / pharmacology
Etoposide / therapeutic use
Female
Hematopoietic Stem Cell Transplantation / methods*
Humans
Male
Melphalan / pharmacology
Melphalan / therapeutic use
Middle Aged
Retrospective Studies
Transplantation Conditioning / methods*
Transplantation, Autologous / methods*
Young Adult

Substances

Cytarabine
Etoposide
Melphalan
Carmustine

Supplementary concepts

BEAM regimen